Heterocyclic compounds

Details Heterocyclic compounds Heterocyclic compounds

2008-07-10

2011-11-22

Bernhardt, Emily (Department: 1624)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Heterocyclic carbon compounds containing a hetero ring...

C514S253010, C514S254020, C544S008000, C544S230000, C544S360000, C544S372000, C546S016000

Reexamination Certificate

active

08063042

ABSTRACT:
The invention is concerned with novel heterocyclyl compounds of formula (I)wherein A, X, Y, R3, R4, R5, R6, R7, R8, R9, R10, m and n are as herein defined, as well as physiologically acceptable salts thereof. These compounds are antagonists of CCR2 receptor, CCR5 receptor and/or CCR3 receptor and can be used as medicaments.

REFERENCES:
patent: 3331830 (1967-07-01), Tomcufcik et al.
patent: 3634411 (1972-01-01), Fauran et al.
patent: 2003/0144277 (2003-07-01), Delucca
patent: 2004/0102450 (2004-05-01), Ewing et al.
patent: 2007/0167470 (2007-07-01), Chen
patent: 2163153 (1986-02-01), None
Wolff, Manfred E. Burger's Medicinal Chemistry, 5th Ed. Part 1, pp. 975-977 (1995).
Banker et al. “Modern Pharmaceutics”, 3rd Ed. p. 596 (1996).
Guo, Z et alTetrahedron Asymmetry, 17 (2006) 2015-2020 XP0025168176.
Seebach D et alHelvetica Chimica Acta, 70 (1987) 1605-1615 XP002516818.
Vice, S et alJour. of Organic Chem. 66:7 (2001) 2487-2492 XP002516941.
Cao, J. et al.J. Med. Chem.. 47 (2004) 6128-6136.

Affiliated with

Also associated with

Rating

Heterocyclic compounds does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Heterocyclic compounds, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Heterocyclic compounds will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4308334